Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-02-22
2005-02-22
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S466000, C549S441000
Reexamination Certificate
active
06858648
ABSTRACT:
A compound having the following Formula:wherein R1, R2, Z, and Y are defined herein, and methods of preparation and application for treating mental disorders and inflammation are provided therewith.
REFERENCES:
patent: 5536506 (1996-07-01), Majeed
patent: 5693327 (1997-12-01), Shah
patent: 6080410 (2000-06-01), Bewicke
patent: 6312735 (2001-11-01), Niazi et al.
patent: 6346539 (2002-02-01), Raman
Banerji et al. Phytochemistry, vol. 59, No. 8, p. 897-901 (Apr. 17, 2002).*
Porsolt Rd, Bertin A, Jalfre M (1977) Behavioural despair in mice: A primary screening test for antidepressants. Arch Int Pharmacodyn 229:327-336.
Porsolt Rd, Le Pichon M, Jalfre M (1977) Depression: A new animal model sensitive to antidepressant treatments. Nature 266:730-732.
Pan Sheng-li
Qian Fu-gang
Shao Yi-ci
Wang Jun
Wen Ren
Dentz Bernard
Fudan University
Jiang Yuan Qing
Shanghai Institute of Pharmaceutical Industry
LandOfFree
Laetispicine and laetispicine analogues, methods of use and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Laetispicine and laetispicine analogues, methods of use and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Laetispicine and laetispicine analogues, methods of use and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3504099